Chronic lymphocytic/lymphoma panel

General information

Panel of markers used: CD3, CD5, CD19, CD23, CD79b, Kappa chains, Lambda chains, FMC7, CD38 (optional markers: CD10, CD11c, CD25, CD103).

Specimen transport: At room temperature in EDTA tube.

Repeat frequency: Post treatment monitoring, suspected relapse and MRD

Special precautions: Do not refrigerate

Reporting units: Percentage of the population of cells of interest

Volume and sample type: 5mls EDTA blood or bone marrow

Method: Flow cytometry

Turnaround time (calendar days from sample receipt to authorised result): Median - 2, 95th percentile - 7

Indications for the test: Haematological malignancies involving lymphoid cells

Factors affecting the test: None

Clinical workstation reference: PHENOTYPING

(Last updated October 7th 2014)